查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855714

按瓣膜類型、手術方式、應用領域和最終用戶分類的人工心臟瓣膜市場－2025-2032年全球預測

Prosthetic Heart Valves Market by Valve Type, Procedure, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人工心臟瓣膜市場規模將達到 277.6 億美元，複合年成長率為 11.93%。

關鍵市場統計數據
基準年 2024 112.6億美元
預計年份：2025年 126.2億美元
預測年份 2032 277.6億美元
複合年成長率 (%) 11.93%

本書全面介紹了影響人工心臟瓣膜生態系統的臨床促進因素、技術進步和相關人員動態。

人工心臟瓣膜領域融合了外科手術傳統和微創創新，並受到臨床需求、人口結構變化和器械技術進步的影響。瓣膜工程和輸送系統的進步拓寬了患者在整個生命週期中的治療選擇，並促使臨床醫生、醫院管理者和支付方之間展開更深入的討論。隨著治療方法的不斷發展，製造商和醫療保健系統面臨的營運和監管要求也隨之改變，促使人們重新評估證據產生、供應鏈韌性和上市後監測策略。

對外科創新、導管擴張術、材料科學和基於價值的醫療需求所帶來的變革性轉變進行詳細分析

在手術技術創新、材料科學突破以及對以患者為中心的治療效果日益重視的推動下，人工心臟瓣膜領域正經歷著變革性的轉變。經導管瓣膜置換術（TVR）技術正迅速成熟，不斷拓展適應症，提升圍手術期安全性；同時，瓣膜框架幾何形狀和瓣葉材料的不斷改進，也提高了瓣膜的耐久性和血流動力學性能。這些技術進步，加上影像、導航和輸送導管的創新，正在降低手術操作的差異性，並拓展複雜解剖結構的手術應用範圍。

分析不斷變化的美國關稅政策和貿易結構調整將如何重塑閥門相關人員的採購、定價和供應鏈策略。

預期中的關稅調整和貿易政策重組將為人工心臟瓣膜領域的相關人員帶來新的複雜性，影響其採購、定價和全球供應鏈策略。關稅制度的變化可能會改變進口零件、成品和輔助耗材的成本結構，迫使製造商重新評估採購和生產分配。積極的策略性因應措施包括重新檢視供應商合約、探索近岸外包方案以及垂直整合機會，以在維持關鍵投入品供應的同時，緩解利潤率下降的局面。

深入的細分分析揭示了瓣膜類型、手術途徑、臨床應用和終端用戶動態如何決定專門的商業和臨床策略。

基於細分市場的洞察揭示了不同瓣膜類型、手術路徑、臨床應用和終端用戶環境下的差異化商業機會和策略重點。在評估瓣膜類型時，機械瓣膜（例如，雙隔膜瓣、籠式球瓣和傾斜盤瓣）具有不同的臨床特徵，會影響後續護理和抗凝血管理；而組織瓣膜（例如，牛、同種異體瓣和豬瓣）則提供了優先考慮生物相容性和減少長期抗凝血需求的方案。這些器械層面的固有差異需要針對性地產生證據並進行臨床醫生培訓，以支持合適的患者選擇和長期管理路徑。

全面深入的區域洞察，比較美洲、中東和非洲以及亞太地區的監管複雜性、應用促進因素和商業性路徑。

區域動態是監管時間表、產品採納率和商業模式的關鍵決定因素，導致美洲、歐洲、中東和非洲以及亞太地區市場進入路徑各不相同。在美洲，成熟的臨床生態系統和完善的醫保報銷體系促進了創新瓣膜技術的快速普及，同時醫療系統也日益關注療效和成本效益，以此指南採購。相較之下，歐洲、中東和非洲的市場監管和支付方環境各不相同，需要製定細緻的打入市場策略，並利用本地臨床證據來支持各地區的市場推廣。

了解領先製造商如何透過創新、夥伴關係、證據累積和卓越的供應鏈管理脫穎而出。

醫療設備製造商之間的競爭力日益取決於臨床證據的整合、供應鏈的韌性以及差異化技術平台。領先企業正投資研發新一代說明書材料、增強耐久性測試以及專有給藥系統，以滿足尚未滿足的臨床需求並拓展適應症。與影像和導航公司建立策略聯盟以及與學術中心合作，正在加速器械的迭代改進，並透過培訓和指導計畫鼓勵臨床醫生儘早採用新產品。

為醫療器材開發商和醫療系統領導者提供切實可行的建議，以協調創新、供應鏈韌性、證據產生和商業性敏捷性

產業領導者應採取一系列切實可行的策略，使研發投資與臨床優先事項、營運韌性和商業性靈活性保持一致。首先，應優先開發模組化瓣膜和輸送平台，以便進行漸進式升級而無需完全重新手術，從而加快臨床醫生接受新產品並降低生命週期成本。同時，應投資持久的臨床前研究和真實世界證據項目，以衡量以患者為中心的療效和長期性能，並支持醫保報銷和適應症擴展。

我們採用透明的調查方法，包括臨床醫生參與、監管分析和證據三角驗證，以深入了解人工瓣膜。

該研究結合了臨床醫生訪談、採購相關人員和器械開發商簡報的第一手資料，並嚴格審查了同行評審的臨床文獻、監管申報文件和手術最佳實踐指南。主要定性研究邀請了介入性心臟病專家、心臟外科醫生、醫院採購負責人和臨床試驗負責人參與，以了解當地對實施障礙、培訓需求和手術結果的觀點。除了這些直接回饋外，研究還評估了監管文件和已發布的上市後監測數據，以檢驗不同瓣膜類型和手術方法的性能描述和安全性概況。

總結全文，重點闡述將技術前景轉化為持續的臨床應用和營運韌性所需的策略要務。

器械創新、手術流程拓展和供應鏈複雜性的整合，為人工心臟瓣膜領域的企業帶來了巨大的機會和新的風險。持久的技術進步和適應症的擴大有望改善患者預後並擴大治療覆蓋範圍，但要實現這些益處，需要嚴謹的循證策略、適應性強的生產方式以及以臨床醫生為中心的推廣模式。隨著貿易政策和報銷框架的不斷演變，採取積極主動、優先考慮韌性和明確價值的策略，對於保持競爭力至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 經導管主動脈瓣置換術在高手術風險老年患者的應用日益增多
  • 開發新型聚合物心臟瓣膜材料，以降低血栓形成傾向並改善動態性能
  • 個人化3D列印技術在設計與安裝患者專用人工心臟瓣膜的應用
  • 擴大微創瓣膜置換術在八旬老人的應用，用於治療生物瓣膜功能衰竭
  • 監管部門的核准加速了新一代球囊擴張型和自擴張式瓣膜的市場准入
  • 加大對經導管二尖瓣和三尖瓣置換療法適應症擴展試驗的投資

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按瓣膜類型分類的人工心臟瓣膜市場

  • 機械的
    • 巴利·阿弗雷特
    • 籠球
    • 傾斜盤
  • 組織
    • 牛
    • 同種異體移植
    • 豬

第9章 依手術方式分類的人工心臟瓣膜市場

  • 手術置換術
    • 微創
    • 傳統開放性手術
  • 經導管瓣膜置換術
    • 經尖端
    • 經股骨

第10章 按應用分類的人工心臟瓣膜市場

  • 主動脈
  • 二尖瓣
  • 三尖瓣

第11章 依最終用戶分類的人工心臟瓣膜市場

  • 門診手術中心
  • 醫院

第12章：按地區分類的人工心臟瓣膜市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 按組別分類的人工心臟瓣膜市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國人工心臟瓣膜市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • CryoLife, Inc.
    • MicroPort Scientific Corporation
    • Braile Biomedica SA
    • JenaValve Technology, Inc.
    • Venus MedTech（Hangzhou）Inc.
Product Code: MRR-62667ADFA787

The Prosthetic Heart Valves Market is projected to grow by USD 27.76 billion at a CAGR of 11.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 11.26 billion
Estimated Year [2025] USD 12.62 billion
Forecast Year [2032] USD 27.76 billion
CAGR (%) 11.93%

Comprehensive introduction framing clinical drivers, technological advances, and stakeholder dynamics reshaping the prosthetic heart valve ecosystem

The prosthetic heart valve sector stands at the intersection of surgical tradition and minimally invasive innovation, shaped by clinical need, demographic shifts, and device technology progress. Advances in valve engineering and delivery systems have expanded therapeutic options for patients across the lifespan, driving more nuanced conversations among clinicians, hospital administrators, and payers. As therapies evolve, so too do the operational and regulatory demands on manufacturers and health systems, prompting a re-evaluation of evidence generation, supply chain resilience, and post-market surveillance strategies.

Transitioning from historical open-heart procedures toward catheter-based interventions has redefined procedural pathways and patient eligibility. Concurrently, the competing design philosophies of mechanical and tissue valves require distinct clinical and commercial approaches, influencing long-term management, follow-up requirements, and prosthesis selection criteria. These dynamics underscore the importance of an integrated perspective that links clinical outcomes, health economics, and real-world adoption patterns to inform strategic decisions across R&D, regulatory affairs, and commercial teams.

Detailed analysis of the transformative shifts driven by surgical innovation, catheter-based expansion, material science, and value-based care imperatives

The prosthetic heart valve landscape is undergoing transformative shifts driven by procedural innovation, material science breakthroughs, and an intensified focus on patient-centred outcomes. Transcatheter valve replacement technologies have matured rapidly, broadening indications and improving peri-procedural safety, while iterative refinements in valve frame geometry and leaflet materials are improving durability and haemodynamic performance. These technical improvements are accompanied by innovations in imaging, navigation, and delivery catheters, which collectively reduce procedural variability and expand access to complex anatomies.

Beyond devices, care delivery models are shifting as multidisciplinary heart teams adopt streamlined pathways that prioritise shorter hospital stays and faster functional recovery. Minimally invasive surgical approaches persist alongside catheter-based treatments, creating a dual-track paradigm where device makers must balance investments across both surgical and transcatheter portfolios. In parallel, reimbursement frameworks and value-based purchasing initiatives are placing greater emphasis on long-term outcomes, quality-of-life metrics, and total cost of care, incentivising manufacturers to demonstrate durable clinical benefit and post-market performance. Taken together, these transformative forces are reshaping competitive positioning, regulatory strategies, and clinical adoption trajectories in a market defined by rapid technological evolution and heightened expectations from clinicians and payers.

Examination of how evolving United States tariff policies and trade realignments could reshape procurement, pricing, and supply chain strategies for valve stakeholders

Anticipated tariff adjustments and trade policy realignments will introduce new layers of complexity into procurement, pricing, and global supply chain strategies for stakeholders in the prosthetic heart valve space. Changes in tariff regimes have the potential to alter cost structures for imported components, finished devices, and ancillary disposables, prompting manufacturers to reassess sourcing footprints and manufacturing allocation. A strategic and proactive response involves re-examining supplier contracts, nearshoring options, and vertical integration opportunities to mitigate margin compression while preserving access to critical inputs.

In addition to direct cost impacts, tariff-related shifts may induce changes in competitive dynamics across regional markets. Manufacturers with existing local manufacturing capabilities or favourable trade agreements will experience relative advantage in procurement discussions, whereas those reliant on cross-border supply chains may face pressure on pricing and lead times. Health systems and ambulatory surgical centres may respond by prioritising value and supply resilience in purchasing decisions, thereby elevating the importance of demonstrable total-cost-of-care benefits and reliable inventory management. Consequently, industry participants should develop flexible pricing architectures and scenario-based supply chain plans that account for tariff volatility and evolving trade policies.

Insightful segmentation analysis revealing how valve type, procedural pathway, clinical application, and end-user dynamics dictate specialised commercial and clinical strategies

Segmentation-driven insights reveal differentiated opportunities and strategic priorities across valve types, procedural channels, clinical applications, and end-user settings. When evaluating valve type, mechanical prostheses-comprising bileaflet, caged ball, and tilting disc designs-present distinct clinical profiles that influence follow-up care and anticoagulation management, while tissue valves-spanning bovine, homograft, and porcine options-offer alternatives prioritising biocompatibility and reduced long-term anticoagulation requirements. These intrinsic device-level differences necessitate tailored evidence generation and clinician education to support appropriate patient selection and long-term management pathways.

Procedure segmentation further nuances go-to-market strategies as surgical replacement pathways, including minimally invasive and traditional sternotomy approaches, coexist with transcatheter valve replacement options executed via transapical and transfemoral access. Manufacturers must therefore calibrate their clinical trials, training programs, and delivery system designs to address access-specific technical constraints and operator preferences. Application-based perspectives focused on aortic, mitral, and tricuspid valve interventions require device optimisation for anatomical variability, durability demands, and imaging compatibility. Finally, end-user segmentation between ambulatory surgical centers and hospitals influences purchasing timelines, capital equipment considerations, and procedural throughput expectations, shaping sales cycles and service model requirements. Integrating these segmentation lenses enables more precise product positioning, evidence strategies, and commercial resource allocation.

Comprehensive regional insights that contrast regulatory complexity, adoption drivers, and commercial pathways across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics are a primary determinant of regulatory timelines, adoption rates, and commercial models, creating diverse pathways to market across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, mature clinical ecosystems and established reimbursement infrastructures facilitate rapid uptake of innovative valve technologies, while health systems increasingly emphasise outcomes and cost-effectiveness to guide procurement. Conversely, markets within Europe, Middle East & Africa feature heterogeneous regulatory environments and varied payer landscapes, requiring nuanced market entry strategies and locally generated clinical evidence to support adoption across sub-regions.

The Asia-Pacific region presents a dual opportunity set, characterised by large patient populations and rapidly expanding procedural capacity, alongside regulatory modernisation and growing investments in domestic manufacturing. Manufacturers aiming to scale in Asia-Pacific must develop culturally attuned clinician engagement programs, flexible pricing models, and supply chain solutions that address regional logistics. Across all regions, strategic alliances with clinical leaders, investments in local data generation, and adaptive commercial models will be critical to navigating differing regulatory expectations, reimbursement policies, and hospital procurement practices. A regionalised approach that balances global standards with local execution is therefore essential for sustainable growth.

In-depth view of how leading manufacturers are differentiating through innovation, partnerships, evidence generation, and supply chain excellence

Competitive dynamics among device manufacturers are increasingly defined by the integration of clinical evidence, supply chain resilience, and differentiated technology platforms. Leading firms are investing in next-generation leaflet materials, enhanced durability testing, and purpose-built delivery systems to address unmet clinical needs and expand indication sets. Strategic partnerships with imaging and navigation companies, as well as collaborations with academic centres, are accelerating iterative device improvements and facilitating earlier clinician adoption through training and proctoring programs.

Beyond product innovation, successful companies demonstrate robust post-market surveillance and patient follow-up frameworks that reinforce clinician confidence and support reimbursement dialogues. Operational excellence in manufacturing and quality assurance, combined with flexible commercial models-including capital-light service offerings and outcomes-based contracting pilots-further differentiates market leaders. As procurement teams increasingly prioritise total cost of care and long-term outcomes, companies that can align clinical evidence with economic arguments and reliable supply will secure stronger positioning in competitive tenders and hospital formularies.

Actionable recommendations for device developers and health system leaders to align innovation, supply resilience, evidence generation, and commercial agility

Industry leaders should pursue a set of actionable strategies that align R&D investment with clinical priorities, operational resilience, and commercial agility. First, prioritise modular valve and delivery platform development that allows incremental upgrades without requiring full procedural retraining, thereby accelerating clinician adoption and reducing lifecycle costs. Concurrently, invest in durable preclinical and real-world evidence programmes that measure patient-centric outcomes and long-term performance to support reimbursement and expanded indications.

Second, develop flexible manufacturing and sourcing strategies to mitigate trade policy and tariff risk, including assessing nearshoring and multi-sourcing options for critical components. Strengthen post-market surveillance and registries to provide transparent safety and performance data that drive payer and clinician confidence. Third, tailor commercial approaches to distinct end-user needs by offering training bundles and service models adapted to the workflows of ambulatory surgical centres and hospitals. Finally, cultivate strategic partnerships with imaging, navigation, and digital health companies to enhance procedural precision and enable integrated care pathways. By executing these priorities, organisations can enhance resilience, accelerate adoption, and demonstrate clear value to clinicians, patients, and payers.

Transparent research methodology describing clinician engagements, regulatory analysis, and evidence triangulation used to derive prosthetic valve insights

This research synthesises primary insights from clinician interviews, procurement stakeholder consultations, and device developer briefings, combined with a rigorous review of peer-reviewed clinical literature, regulatory filings, and procedural best-practice guidelines. Primary qualitative engagements targeted interventional cardiologists, cardiac surgeons, hospital procurement leaders, and clinical trialists to capture frontline perspectives on adoption barriers, training needs, and procedural outcomes. These direct inputs were complemented by an assessment of regulatory documents and published post-market surveillance data to validate performance narratives and safety profiles across valve types and procedural approaches.

Analytical methods included thematic coding of qualitative interviews, cross-validation of device performance claims against regulatory summaries, and scenario analysis to explore supply chain and tariff sensitivities. Wherever possible, evidence triangulation was used to reconcile clinician-reported experiences with registry publications and regulatory decisions. The methodology emphasises transparency in data sources and incorporates stakeholder validation to ensure that conclusions reflect real-world operational and clinical realities rather than solely promotional narratives.

Conclusive synthesis emphasising the strategic imperatives needed to translate technological promise into sustained clinical adoption and operational resilience

The convergence of device innovation, procedural expansion, and supply chain complexity is creating both significant opportunities and novel risks for organisations operating in the prosthetic heart valve domain. Durable technological improvements and expanding indications have the potential to improve patient outcomes and broaden therapy access, but realising those benefits requires disciplined evidence strategies, adaptive manufacturing, and clinician-focused deployment models. As trade policies and reimbursement frameworks evolve, a proactive posture that prioritises resilience and clear value articulation will be essential to maintain competitive positioning.

Looking ahead, stakeholders that integrate rigorous clinical evidence, flexible commercial models, and robust supply chain planning will be better positioned to capitalise on clinical advances while mitigating policy and market volatility. Cross-functional collaboration across clinical, regulatory, and commercial teams will be critical to translating innovation into sustained adoption and improved patient care. Ultimately, success will be defined by the ability to align technological promise with practical implementation strategies that deliver measurable benefits to patients and health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of transcatheter aortic valve implantation in high surgical risk and elderly patients
  • 5.2. Development of novel polymeric heart valve materials to reduce thrombogenicity and enhance hemodynamic performance
  • 5.3. Emergence of personalized 3D printing techniques for patient-specific prosthetic heart valve design and fit
  • 5.4. Expansion of minimally invasive valve-in-valve implantation procedures for failed bioprosthetic valves in octogenarians
  • 5.5. Regulatory approvals accelerating market entry of next-generation balloon expandable and self expanding valves
  • 5.6. Growing investment in extended indication trials for transcatheter mitral and tricuspid valve replacement therapies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Prosthetic Heart Valves Market, by Valve Type

  • 8.1. Mechanical
    • 8.1.1. Bileaflet
    • 8.1.2. Caged Ball
    • 8.1.3. Tilting Disc
  • 8.2. Tissue
    • 8.2.1. Bovine
    • 8.2.2. Homograft
    • 8.2.3. Porcine

9. Prosthetic Heart Valves Market, by Procedure

  • 9.1. Surgical Replacement
    • 9.1.1. Minimally Invasive
    • 9.1.2. Traditional Sternotomy
  • 9.2. Transcatheter Valve Replacement
    • 9.2.1. Transapical
    • 9.2.2. Transfemoral

10. Prosthetic Heart Valves Market, by Application

  • 10.1. Aortic
  • 10.2. Mitral
  • 10.3. Tricuspid

11. Prosthetic Heart Valves Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Prosthetic Heart Valves Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Prosthetic Heart Valves Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Prosthetic Heart Valves Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Edwards Lifesciences Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Abbott Laboratories
    • 15.3.4. Boston Scientific Corporation
    • 15.3.5. LivaNova PLC
    • 15.3.6. CryoLife, Inc.
    • 15.3.7. MicroPort Scientific Corporation
    • 15.3.8. Braile Biomedica S.A.
    • 15.3.9. JenaValve Technology, Inc.
    • 15.3.10. Venus MedTech (Hangzhou) Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. PROSTHETIC HEART VALVES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. PROSTHETIC HEART VALVES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PROSTHETIC HEART VALVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 306. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 307. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 308. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 309. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 310. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 311. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 312. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 313. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 314. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 315. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION PROSTHET